Publication: Clinical Pharmacology & Therapeutics
Abstract
Quantitative Systems Pharmacology (QSP) and Pharmacometrics (PMX) have historically existed at the two ends of the model-informed drug development (MIDD) spectrum. The session “Mind the gap – successful bridging of QSP and PMX in drug development” at the 2024 American Conference of Pharmacometrics brought together QSP scientists and pharmacometricians with the aim to develop better understandings of how to bridge this gap. The current perspective is based on the concepts that were presented and the follow-up panel discussion.
Author(s): Georgi I. Kapitanov, Justin C. Earp, Kapil Gadkar, Jin Y. Jin, Amita Joshi, Anna G. Kondic, Cynthia J. Musante, Blerta Shtylla, Mirjam N. Trame, Piet H. van der Graaf
Year: 2025 年 12 月 30 日
Learn more about QSP Consulting Services
Learn how Certara partners with drug developers to design, calibrate, and validate mechanistic models that derisk and accelerate drug development.
